Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Allogeneic Cell Therapy Market to reach USD 1773.85 million by the end of 2030

Global Allogeneic Cell Therapy Market Size study & Forecast, by Therapy Type (Stem Cell Therapies, Non-stem Cell Therapies), by Therapeutic Area (Hematological Disorders, Dermatological Disorders and Others), and Regional Analysis, 2023-2030

Product Code: HLSDT-39040854
Publish Date: 20-05-2023
Page: 200

Global Allogeneic Cell Therapy Market is valued at approximately USD 255.6 million in 2022 and is anticipated to grow with a healthy growth rate of more than 27.40% over the forecast period 2023-2030. Allogeneic cell therapy is a type of cellular therapy that involves the use of cells from a donor to treat a patient. In this type of therapy, cells are collected from a healthy donor and are then processed and expanded in a laboratory setting before being infused into the patient. The cells used in allogeneic cell therapy can be various types of cells, including stem cells, immune cells, or other specialized cells that have therapeutic potential. The cells are typically selected based on their ability to replace damaged or dysfunctional cells in the patient’s body or to modulate the immune system to fight a particular disease. The Allogeneic Cell Therapy Market is being driven by factors such as the rising prevalence of cancer and increasing FDA approvals of allogeneic cell therapies.

Allogeneic cell therapy has been used to treat a range of diseases, including cancer, genetic disorders, and autoimmune diseases. The therapy has shown promising results in clinical trials, and researchers are continuing to investigate its potential for treating a variety of conditions. The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), it is estimated that worldwide burden of cancer is projected to reach 27.5 million new cases by 2040 from 1.9 million new cases in the year 2021. Clinical trials for cell therapies have increased as a result of the growing demand for cutting-edge medical treatments for chronic disorders. According to information provided by, there were 1,358 active cell therapy trials as of April 2021, up from 24% from 2019 to 2020 and a 43% rise from 2020 to 2021. Clinical studies for CAR-T cells, which have expanded by 83%, account for most of this expansion. Thus, the rising number of clinical trials across the world is catering the market growth. In addition, increasing government funding for stem cell therapies and rising cell-based clinical trial activities are creating lucrative growth in the market. The BLA is planned to be submitted by the end of Q4 2023. The successful launch of this Therapy Typemay provides patients with an alternative option. However, the high cost of Allogeneic Cell Therapy stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Allogeneic Cell Therapy Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in 2022 as a result of the popularity of branded goods and the region’s rising disease rates. Approximately 37.3 million Americans will have diabetes in 2020, including 28.7 million cases that have already received a diagnosis and 8.5 million cases that haven’t. Asia Pacific is anticipated to grow at the highest CAGR during the forecast period due to factors like expanding geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of governmental and nonprofit organizations in the market space.

Major market player included in this report are:
JCR Pharmaceuticals Co., Ltd.
Sumitomo Pharma Co., Ltd.
Atara Biotherapeutics Inc.
Mallinckrodt Pharmaceuticals
Tego Science Inc.
Takeda Pharmaceutical Company Limited.
Biosolution Co., Ltd.
LifeSouth Community Blood Centers, Inc.

Recent Developments in the Market:
Ø In January 2022, Bristol Myers Squibb, and Century Therapeutics collaborated to create allogeneic therapies for solid tumours and hematologic malignancies using iPSC-derived stem cells.
Ø In October 2022, Allogene Therapeutics introduces CAR T TogetherTM, a groundbreaking collaboration with leading oncologists across the nation, with the aim of speeding the development and enrollment in clinical trials for investigational “off-the-shelf” allogeneic , chimeric antigen receptor (CAR) T products to make CAR T therapy scalable and more accessible to patients with certain cancers.

Global Allogeneic Cell Therapy Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Therapy Type, Therapeutic Area, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Therapy Typeofferings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy Type:
Stem Cell Therapies
Non-stem Cell Therapies

By Therapeutic Area:
Hematological Disorders
Dermatological Disorders

By Region:
North America
Asia Pacific
South Korea
Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Allogeneic Cell Therapy Market, by Region, 2020-2030 (USD Million)
1.2.2. Allogeneic Cell Therapy Market, by Therapy Type, 2020-2030 (USD Million)
1.2.3. Allogeneic Cell Therapy Market, by Therapeutic Area, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Allogeneic Cell Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Allogeneic Cell Therapy Market Dynamics
3.1. Allogeneic Cell Therapy Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Rising prevalence of cancer Increasing FDA approvals of allogeneic cell therapies
3.1.2. Market Challenges High research costs and challenges with immune rejection
3.1.3. Market Opportunities Increasing government funding for stem cell therapies Rising cell based clinical trial activities
Chapter 4. Global Allogeneic Cell Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Allogeneic Cell Therapy Market, by Therapy type
5.1. Market Snapshot
5.2. Global Allogeneic Cell Therapy Market by Therapy type, Performance – Potential Analysis
5.3. Global Allogeneic Cell Therapy Market Estimates & Forecasts by Therapy type 2020-2030 (USD Million)
5.4. Allogeneic Cell Therapy Market, Sub Segment Analysis
5.4.1. Stem Cell Therapies
5.4.2. Non-stem Cell Therapies
Chapter 6. Global Allogeneic Cell Therapy Market, by Therapeutic Area
6.1. Market Snapshot
6.2. Global Allogeneic Cell Therapy Market by Therapeutic Area, Performance – Potential Analysis
6.3. Global Allogeneic Cell Therapy Market Estimates & Forecasts by Therapeutic Area 2020-2030 (USD Million)
6.4. Allogeneic Cell Therapy Market, Sub Segment Analysis
6.4.1. Haematological Disorders
6.4.2. Dermatological Disorders
6.4.3. Others
Chapter 7. Global Allogeneic Cell Therapy Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Allogeneic Cell Therapy Market, Regional Market Snapshot
7.4. North America Allogeneic Cell Therapy Market
7.4.1. U.S. Allogeneic Cell Therapy Market Therapy type breakdown estimates & forecasts, 2020-2030 Therapeutic Area breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Allogeneic Cell Therapy Market
7.5. Europe Allogeneic Cell Therapy Market Snapshot
7.5.1. U.K. Allogeneic Cell Therapy Market
7.5.2. Germany Allogeneic Cell Therapy Market
7.5.3. France Allogeneic Cell Therapy Market
7.5.4. Spain Allogeneic Cell Therapy Market
7.5.5. Italy Allogeneic Cell Therapy Market
7.5.6. Rest of Europe Allogeneic Cell Therapy Market
7.6. Asia-Pacific Allogeneic Cell Therapy Market Snapshot
7.6.1. China Allogeneic Cell Therapy Market
7.6.2. India Allogeneic Cell Therapy Market
7.6.3. Japan Allogeneic Cell Therapy Market
7.6.4. Australia Allogeneic Cell Therapy Market
7.6.5. South Korea Allogeneic Cell Therapy Market
7.6.6. Rest of Asia Pacific Allogeneic Cell Therapy Market
7.7. Latin America Allogeneic Cell Therapy Market Snapshot
7.7.1. Brazil Allogeneic Cell Therapy Market
7.7.2. Mexico Allogeneic Cell Therapy Market
7.8. Rest of The World Allogeneic Cell Therapy Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. JCR Pharmaceuticals Co., Ltd. Key Information Overview Financial (Subject to Data Availability) Therapy TypeSummary Recent Developments
8.3.2. Sumitomo Pharma Co., Ltd.
8.3.3. Atara Biotherapeutics Inc.
8.3.4. Mallinckrodt Pharmaceuticals
8.3.5. Tego Science Inc.
8.3.6. Takeda Pharmaceutical Company Limited.
8.3.8. Biosolution Co., Ltd.
8.3.9. MEDIPOST Co., Ltd.
8.3.10. LifeSouth Community Blood Centers, Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now